CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-10 | BENEVICH ERIC Director | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2024-07-24 | SCHIMMEL PAUL Director | Purchase | +52,300 | $1.93 | $101K | 413,023 |
| 2024-07-23 | SCHIMMEL PAUL Director | Purchase | +6,648 | $1.82 | $12K | 360,723 |
| 2024-07-22 | SCHIMMEL PAUL Director | Purchase | +41,052 | $1.74 | $72K | 354,075 |
| 2024-06-05 | DENYES NANCY General Counsel | Purchase | +5,000 | $1.86 | $9K | 22,267 |
| 2024-05-31 | Broadfoot Jill Marie Chief Financial Officer | Purchase | +5,000 | $1.79 | $9K | 27,960 |
| 2024-05-31 | Shukla Sanjay President and CEO | Purchase | +20,000 | $1.81 | $36K | 136,548 |
| 2024-05-30 | COUGHLIN TIMOTHY Director | Purchase | +50,000 | $1.75 | $88K | 56,000 |
| 2024-05-22 | CLARKE JOHN K Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2024-05-22 | Gross Jane A Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2024-05-22 | Lucas Svetlana Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2024-05-22 | SCHIMMEL PAUL Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2024-05-22 | Zaknoen Sara Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2024-05-22 | COUGHLIN TIMOTHY Director | Grant or award · Stock Option (right to buy) | +24,000 | 24,000 | ||
| 2024-02-06 | Broadfoot Jill Marie Chief Financial Officer | Sale | −1,590 | $1.69 | $3K | 20,821 |
| 2024-02-05 | Shukla Sanjay President and CEO | Option exercise | +10,375 | 116,548 | ||
| 2024-02-05 | Shukla Sanjay President and CEO | Option exercise · Restricted Stock Unit | −10,375 | 20,750 | ||
| 2024-02-05 | Broadfoot Jill Marie Chief Financial Officer | Option exercise | +3,750 | 22,411 | ||
| 2024-02-05 | Broadfoot Jill Marie Chief Financial Officer | Option exercise · Restricted Stock Unit | −3,750 | 7,500 | ||
| 2024-02-05 | DENYES NANCY General Counsel | Option exercise | +2,688 | 14,767 |
Page 3 of 15 · 284 trades